Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15-Dec-2025 | Source : BSEThis is to inform that the Earnings Call of the Company with Analysts/Investors to discuss the operational & financial performance for the quarter and half year ended on September 30 2025 is scheduled on Monday 22nd December 2025 at 11:30 A.M.
Board Meeting Intimation for Adoption Of Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025 And Other Business Items
15-Dec-2025 | Source : BSESudeep Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/12/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended on September 30 2025 and other Business items
Intimation Of Unsecured Loan Granted To Sudeep Advanced Materials Private Limited A Wholly Owned Subsidiary (WOS) Of The Company
09-Dec-2025 | Source : BSEPursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations 2015 as amended we hereby inform you that the Company has granted an unsecured Loan to Sudeep Advanced Materials Private Limited a wholly owned subsidiary (WOS) of the Company.
Corporate Actions
(19 Dec 2025)
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






